New Delhi: The Goa government on Monday called 'ivermectin' - an orally administered drug used to treat COVID-19 patients over 18 years of age - used to treat parasitic infections. Approved as.
Health Minister Vishwajit Rane said that the drug would be available in all health centers, and urged them all to be eligible to take the drug even if there are no symptoms of coronovirus. He called it "prophylactic treatment as prophylactic".
"Patients will be treated with ivermectin 12mg for a period of five days. An expert panel from the UK, Italy, Spain, and Japan has found a large, statistically significant reduction in mortality rates in patients treated with COVID-19. And timely treatment with viral clearance of recovery. Ivermectin, "he said.
What does the drug maker say?
On 4 February, Merck - the German company that makes ivermectin, said that at this time, "the analysis did not identify any meaningful evidence for clinical activity or efficacy in patients with COVID-19 disease". The company stated that "available data support the safety and efficacy of ivermectin beyond the doses and populations indicated in the regulators".
What does the World Health Organization say?
The WHO has already issued a warning about the common use of 'ivermectin'. This was back in March when the global health body said that there was "very little certainty of evidence" of the drug's effect on mortality or hospital admission.
On Tuesday morning, WHO Chief Scientist Drs. Soumya Swaminathan repeated that warning.
"Safety and efficacy are important when using any medication for a new indication. WHO recommends against the use of 'ivermectin' for COVID-19 in addition to clinical trials," he tweeted.
What do other regulators say?
Both the FDA and the European Medical Agency of the United States have advised against the use of 'ivermectin' to treat COVID-19 patients at this level.
"The FDA has not approved ivermectin for use in the treatment or prevention of COVID-19 in humans. Ivermectin tablets are approved at very specific doses for some parasitic worms and include topical (on the skin) head. Lice and skin conditions such as rosacea occur., ”The FDA stated.
"This ivermectin is not an anti-viral (a drug to treat the virus)," it emphasized.
In March the EMA issued a similar statement, stating that it "reviewed the latest evidence of the use of ivermectin for the prevention and treatment of COVID-19 and concluded that the available data are of its use for COVID-19. Do not support those that are well-designed diagnostic. Testing. "
What do some studies say?
There are studies that suggest ''ivermectin'' is a viable treatment option, such as a review of available data - published in the May – June issue of the American Journal of Therapeutics.
"We conducted the most comprehensive review of the available data on ivermectin," said Pierre Corrie, president and chief medical officer of the Front Line COVID-19 Critical Care Alliance (FLCCC), a group of medical and scientific experts.
The authors claim mortality, a large and statistically significant decrease for recovery, and viral clearance for treatment with 'ivermectin' in COVID-19 patients.
Posts
